Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus
Like all prescription therapies, GLP-1s have potential side effects and are not appropriate for everyone
Podiatric Wound Care Any foot or ankle problem that affects your ability to walk can negatively impact your quality of life
M.MengY.GregoryJ.et al
Following US Food and Drug Administration approvals, GLP-1 (glucagon-like peptide-1) receptor agonists such as type 2 diabetes drug semaglutide have revolutionised the international weight-loss industry by suddenly offering surprisingly effective obesity treatments
Consequently, increasing attention has been given to zinc-based nanoparticles, such as ZIF-8, ZnO, ZnO, ZnS, and Zn-LDH, as potential enhancers of anticancer treatments [29]
US$ 24.83
US$ 23.94
US$ 20.03
US$ 20.75
